X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE AJANTA PHARMA TTK HEALTHCARE/
AJANTA PHARMA
 
P/E (TTM) x 19.3 22.8 84.9% View Chart
P/BV x 2.3 4.4 51.9% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 TTK HEALTHCARE   AJANTA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
AJANTA PHARMA
Mar-18
TTK HEALTHCARE/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4581,818 80.2%   
Low Rs7951,106 71.9%   
Sales per share (Unadj.) Rs408.7239.5 170.7%  
Earnings per share (Unadj.) Rs12.952.8 24.4%  
Cash flow per share (Unadj.) Rs23.659.5 39.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs164.9230.0 71.7%  
Shares outstanding (eoy) m14.1388.77 15.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.86.1 45.1%   
Avg P/E ratio x87.627.7 316.3%  
P/CF ratio (eoy) x47.624.6 193.9%  
Price / Book Value ratio x6.86.4 107.5%  
Dividend payout %38.90-   
Avg Mkt Cap Rs m15,916129,782 12.3%   
No. of employees `0002.26.8 33.0%   
Total wages/salary Rs m1,0903,765 29.0%   
Avg. sales/employee Rs Th2,573.83,128.4 82.3%   
Avg. wages/employee Rs Th485.7554.0 87.7%   
Avg. net profit/employee Rs Th81.0689.7 11.7%   
INCOME DATA
Net Sales Rs m5,77621,258 27.2%  
Other income Rs m76242 31.3%   
Total revenues Rs m5,85121,499 27.2%   
Gross profit Rs m4266,584 6.5%  
Depreciation Rs m152596 25.6%   
Interest Rs m474 1,153.7%   
Profit before tax Rs m3026,226 4.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1201,539 7.8%   
Profit after tax Rs m1824,686 3.9%  
Gross profit margin %7.431.0 23.8%  
Effective tax rate %39.724.7 160.7%   
Net profit margin %3.122.0 14.3%  
BALANCE SHEET DATA
Current assets Rs m2,55612,236 20.9%   
Current liabilities Rs m1,6753,461 48.4%   
Net working cap to sales %15.341.3 36.9%  
Current ratio x1.53.5 43.2%  
Inventory Days Days3360 55.5%  
Debtors Days Days3584 41.4%  
Net fixed assets Rs m1,10311,140 9.9%   
Share capital Rs m141177 79.9%   
"Free" reserves Rs m2,18820,237 10.8%   
Net worth Rs m2,33020,414 11.4%   
Long term debt Rs m710 65.3%   
Total assets Rs m4,07324,486 16.6%  
Interest coverage x7.41,519.4 0.5%   
Debt to equity ratio x00 572.6%  
Sales to assets ratio x1.40.9 163.3%   
Return on assets %5.619.2 29.4%  
Return on equity %7.823.0 34.0%  
Return on capital %14.930.5 48.9%  
Exports to sales %3.00-   
Imports to sales %0.60-   
Exports (fob) Rs m172NA-   
Imports (cif) Rs m35NA-   
Fx inflow Rs m17211,667 1.5%   
Fx outflow Rs m551,616 3.4%   
Net fx Rs m11710,052 1.2%   
CASH FLOW
From Operations Rs m2532,854 8.9%  
From Investments Rs m-226-2,604 8.7%  
From Financial Activity Rs m-72-2 3,600.0%  
Net Cashflow Rs m-41248 -16.6%  

Share Holding

Indian Promoters % 65.4 73.8 88.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 1.6 238.7%  
FIIs % 5.2 7.6 68.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.0 151.8%  
Shareholders   12,723 20,968 60.7%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SANOFI INDIA  ABBOTT INDIA  PLETHICO PHARMA  CIPLA  TORRENT PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend; Sensex Ends 495 Points Lower(Closing)

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 22, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS